Sangamo BioSciences | SGMO - Trade Debtors


Sangamo BioSciences reported $581K in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Amgen USD 10.23B 1.09B Jun/2026
Bayer EUR 18.7B 146M Jun/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Cipla INR 62.19B 12.42B Mar/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.34M 44K Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Grifols EUR 1B 285.88M Dec/2025
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Omeros USD 8.08M 440K Jun/2024
Pfizer USD 16.19B 19M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 492M 10M Jun/2026
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026